BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
Mylan Inc. (MYL) Launches First Generic ORTHO EVRA® Patch 4/17/2014  More...
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/17/2014  More...
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014  More...
Apricus Biosciences (APRI)' Partner In The United Kingdom Accepts First Shipment Of Vitaros® 4/16/2014  More...
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic RENVELA® 4/16/2014  More...
Dr. Reddy's Laboratories Ltd. (RDY)’ Announces The Launch Of Eszopiclone Tablets C-IV 4/16/2014  More...
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014  More...
FDA Extends Market Exclusivity Six Months For BioMarin Pharmaceutical Inc. (BMRN)'s Rare Disease Therapy KUVAN® (Sapropterin Dihydrochloride) Powder For Oral Solution And Tablets 4/14/2014  More...
Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. (GILD) Still Leads 4/11/2014  More...
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014  More...
AbbVie (ABBV) Announces Availability Of New Advanced Parkinson's Treatment In Canada 4/10/2014  More...
Ironwood Pharmaceuticals (IRWD) And Forest Laboratories, Inc. (FRX) Launch New Direct-To-Consumer Awareness Campaign For LINZESS® 4/10/2014  More...
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. (GILD) To Cut Price Of Sovaldi 4/9/2014  More...
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014  More...
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014  More...
ULURU Inc. Release: Initial Pharmacoeconomic Data Demonstrates Cost Benefits Of Altrazeal® 4/7/2014  More...
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014  More...
Zogenix, Inc. (ZGNX) Statement: Let's Get The Facts Straight About Zohydro ER 4/3/2014  More...
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014  More...
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014  More...
Sagent Pharmaceuticals, Inc. Announces The Launch Of Adenosine Injection, USP 3/31/2014  More...
Mission Pharmacal Company Introduces New And Improved Version Of Top-Selling Prescription Prenatal Vitamin, Citranatal Harmony® 3/28/2014  More...
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets 3/27/2014  More...
Genzyme Corporation (GENZ) Release: U.S. Prescribing Information For Thyrogen Revised To Include Use Of Wider Range Of Radioiodine In Patients 3/27/2014  More...
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014  More...
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014  More...
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014  More...
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014  More...
Quinnova Pharmaceuticals, Inc. Announces The Launch Of ECOZA™ (Econazole Nitrate) Topical Foam, 1% 3/18/2014  More...
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014  More...
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014  More...
National Institute of Clinical Research Turns Down Celgene (CELG)'s Revlimid 3/17/2014  More...
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014  More...
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014  More...
Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product 3/13/2014  More...
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014  More...
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014  More...
Mylan Inc. (MYL) Launches Naloxone Hydrochloride Injection 3/12/2014  More...
Bayer HealthCare (BAY) Launches Eight New Products To Treat Flea And Tick Infestations 3/12/2014  More...
Perrigo Company (PRGO) Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets 3/12/2014  More...
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014  More...
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014  More...
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014  More...
McNeil Consumer Healthcare Release: The Makers of ZYRTEC® Launch New Dissolve Tabs 3/6/2014  More...
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014  More...
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets 3/5/2014  More...
Citron Research Says Prized Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Drug Missing Key Ingredient 3/4/2014  More...
Dendreon Corporation (DNDN) Announces Plans To Make PROVENGE® Commercially Available In Europe 3/3/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces The U.S. Commercial Launch Of ADASUVE® By Teva Pharmaceutical Industries Limited (TEVA) 3/3/2014  More...
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014  More...
Easton Pharmaceuticals (OP: EAPH) Announces The Launching Of Hempstral SA, A New Hemp Based Anti Ageing Product & Reaches Marketing Develop And Distribution Agreement With Hemplifetoday.Com 2/28/2014  More...
Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug 2/28/2014  More...
Cell Therapeutics, Inc. (CTIC) Release: National Institute for Clinical Excellence (NICE) Publishes Final Guidance On PIXUVRI® (pixantrone) 2/27/2014  More...
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Bexsero®: First Vaccine To Prevent Meningococcal Serogroup B (MenB) Now Available In Canada 2/26/2014  More...
Records Show Boehringer Ingelheim Corporation Did Not Disclose Pradaxa Analysis To FDA 2/26/2014  More...
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014  More...
Amarin Corporation PLC (AMRN) Announces FDA Award Of Three-Year Exclusivity For Vascepa® (Icosapent Ethyl) Capsules 2/24/2014  More...
Fresenius Kabi AG Release: Acetylcysteine Solution, USP 20% In 4 ML Vials Now Available 2/24/2014  More...
Forest Laboratories, Inc. (FRX) Launches STRIDE Patient Support Program For COPD Franchise Products Tudorza® Pressair® And Daliresp® 2/24/2014  More...
Gilead Sciences, Inc. (GILD) Close To Dominating Second Multibillion Market With Solvadi 2/24/2014  More...
National Institute for Clinical Excellence (NICE) Turns Down Biogen Idec, Inc. (Massachusetts) (BIIB)'s Oral MS Drug 2/24/2014  More...
Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States 2/21/2014  More...
Afaxys Pharmaceuticals Release: Aubra™ Coverage Expands Significantly 2/21/2014  More...
Axxess Pharma, Inc. Announces Launch Of US TapouT Sales: Initial PO Through NPI, Nutritional Products International, A Leading Brand Management Company 2/18/2014  More...
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014  More...
Alvogen Launches Inflectra In Europe With Hospira, Inc. 2/13/2014  More...
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014  More...
Gilead Sciences, Inc. (GILD) COO: Analysts' Sky-High Hep C Drug View "Not Unreasonable" 2/12/2014  More...
FDA Panel Votes Down Heart Safety Claim For Aleve 2/11/2014  More...
Zogenix, Inc. Provides Update On Zohydro™ ER (Hydrocodone Bitartrate) Launch Readiness Plans 2/11/2014  More...
FDA Panel To Weigh Painkiller' Cardiac Risk 2/10/2014  More...
pSivida Corp (PSDV) Announces ILUVIEN® For DME Accepted By National Health Service Scotland 2/10/2014  More...
Nuvo Research Inc. (NRI.TO) Announces The U.S. Commercial Launch Of PENNSAID® 2% By Mallinckrodt Pharmaceuticals (MNK) 2/10/2014  More...
Mallinckrodt Pharmaceuticals (MNK)’ New Drug Available To Patients 2/10/2014  More...
Eisai Inc. (ESALF.PK) Reports Improved Patient Access For BELVIQ® (lorcaserin HCI) CIV 2/10/2014  More...
Arena Pharmaceuticals, Inc. (ARNA) Reports Coverage For BELVIQ® (Lorcaserin Hcl) CIV Now Greater Than 50% Of Insured Commercial Lives 2/10/2014  More...
Covis Pharmaceuticals Announces Its New Expanded Dosage Options Of LANOXIN® For Cardiac Patients With Mild-To-Moderate Heart Failure 2/7/2014  More...
All Physicians In Switzerland Are Now Able To Prescribe Sucampo Pharmaceuticals, Inc. (SCMP)'s AMITIZA® For Chronic Idiopathic Constipation 2/6/2014  More...
Sanofi (France) (SAN.PA)'s Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without A Prescription In The U.S. 2/4/2014  More...
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014  More...
Gilead Sciences, Inc. (GILD)'s $84,000 Hepatitis C Drug Sets Off Payer Revolt 1/30/2014  More...
Bayer HealthCare (BAY)'s Annihilator™ Polyzone® Makes Insect Control Easy All Season Long 1/29/2014  More...
Mylan Inc. (MYL) Launches Generic Prandin® Tablets 1/24/2014  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014  More...
Avion Pharmaceuticals Announces The Launch Of Prenate® Enhance And Prenate® Restore 1/23/2014  More...
Takeda Pharmaceuticals And Lundbeck Inc. (LUN.CO) Announce Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In Pharmacies 1/23/2014  More...
Ipsen (IPN.PA) Implements A New Governance In The United States To Prepare For The Launch Of Somatuline® In Oncology 1/22/2014  More...
American Regent, Inc. Expands Promotional Campaign For Iron Deficiency Anemia Drug Injectafer® (Ferric Carboxymaltose Injection) 1/22/2014  More...
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014  More...
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014  More...
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014  More...
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014  More...
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014  More...
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014  More...
Par Pharmaceutical, Inc. Begins Shipment Of Generic Lanoxin® 1/17/2014  More...
Ariad Pharmaceuticals, Inc. (ARIA) Announces The Commercial Availability Of Iclusig (Ponatinib) For Patients With Refractory Philadelphia-Positive Leukemias In The U.S. 1/17/2014  More...
Heritage Pharmaceuticals Announces The Launch Of Prochlorperazine Injection 1/16/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014  More...
Antares Pharma, Inc. (AIS) Announces Availability Of OTREXUP (Methotrexate) Injection For Subcutaneous Use To Treat Rheumatoid Arthritis (RA) And Psoriasis In Adults, And Polyarticular Idiopathic Arthritis (Pjia) In Children 1/15/2014  More...
Axxess Pharma, Inc. Announces Launch Of New TapouT Product "TapouT Extreme Muscle" 1/14/2014  More...
pSivida Corp (PSDV) Reports First Orders For ILUVIEN® Shipped For U.K. National Health Service Hospitals Less Than Seven Weeks After Final National Institute for Clinical Excellence (NICE) Guidance 1/13/2014  More...
Alimera Sciences (ALIM) Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals 1/13/2014  More...
CorMedix (CRMD) Expands Neutrolin® Sales With Middle East Distribution Agreements 1/13/2014  More...
Innovus Pharma Provides Regulatory And Commercial Update On The Label Indication For Zestra® For Female Sexual Desire Disorder ("FSDD") From Health Canada 1/10/2014  More...
Mylan Inc. (MYL) Launches Generic Detro® LA Capsules 1/8/2014  More...
Cell Therapeutics, Inc. (CTIC)'s PIXUVRI® Gets Good News From The UK 1/7/2014  More...
Amneal Pharmaceuticals Announces Launch Of Esomeprazole Strontium 49.3 Mg Delayed-Release Capsules Authorized Generic 1/6/2014  More...
FDA Plans New Safety Assessment Of Boehringer Ingelheim Corporation's Pradaxa 1/6/2014  More...
UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy 1/6/2014  More...
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Drug Fycompa In U.S. 1/6/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Authorized Generic Of Detrol® 1/3/2014  More...
Horizon Pharma, Inc. (HZNP) Announces Availability Of Horizon-Labeled VIMOVO(R) In The United States 1/3/2014  More...
Iroko Pharmaceuticals's ZORVOLEX™ Now Available 1/3/2014  More...
Eisai Inc. (ESALF.PK) Announces U.S. Availability Of FYCOMPA™ (Perampanel) CIII An Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy Age 12 And Older 1/2/2014  More...
China Halts Imports Of Pfizer Inc. (PFE)'s Diflucan On Paperwork Glitch 12/31/2013  More...
Morning-After Pill Available By Vending Machine On Campus, University of Pennsylvania Reveals 12/31/2013  More...
Sagent Pharmaceuticals, Inc. Announces The Launch Of Octreotide Acetate Injection 12/27/2013  More...
Immune Response BioPharma Sets U.S. REMUNE Pricing Range $75-250 Per Dose 12/27/2013  More...
PhotoCure Release: Regulatory Update On Cevira 12/27/2013  More...
Federal Appeals Court Ruling Affirms Amneal Pharmaceuticals’s Green Light to Market New Esomeprazole Strontium Delayed-Release Capsules 12/23/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Comes Roaring Back As FDA OKs Bringing Cancer Drug Back To Market; Stock Up +16.49% At Market Close (Dec. 20, 2013) 12/20/2013  More...
Forest Laboratories, Inc. (FRX) Announces New FETZIMA™ (Levomilnacipran ER Capsules) Now Available In Pharmacies Throughout U.S. 12/19/2013  More...
Lupin Ltd. (LUPN.BO) Launches Generic Trizivir® Tablets In The US 12/18/2013  More...
Ipsen (IPN.PA) Prepares For The Resupply Of Increlex® In Europe 12/18/2013  More...
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Norway And Sweden 12/18/2013  More...
Amneal Pharmaceuticals Launches Esomeprazole Strontium 49.3 mg Delayed-Release Capsules, A Pharmaceutical Alternative To Nexium® 12/17/2013  More...
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C 12/16/2013  More...
Acetylcysteine Solution, USP 20% In 10 Ml Vials Now Available From Fresenius Kabi AG 12/16/2013  More...
EMD Group (EMD Millipore (Massachusetts))'s Redesigned Fertility Pen Available for Distribution In U.S. 12/16/2013  More...
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Pull Diabetes Drug From Germany 12/16/2013  More...
Orexo AB (ORXOF) Announces The Launch Of Abstral® In Japan 12/12/2013  More...
XYMOGEN Launches Adrenal Manager Supplement To Help Control Bodily Response To Stress 12/12/2013  More...
CorMedix (CRMD) Announces First Sales Of Neutrolin® In The European Union 12/12/2013  More...
Citron Pharma Launches A Generic Version Of Cymbalta®, Delayed Release Capsules 12/12/2013  More...
Adults Turn To ADHD Drug to Enhance Work Performance 12/11/2013  More...
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013  More...
Medivir AB (MVRBF)'s Simeprevir Is Now Available For Hepatitis C Patients In Japan, USA And Canada 12/10/2013  More...
Biologics, Inc. (NC) Announces Collaborative Program Partnership For YERVOY® (Ipilimumab) Patients 12/9/2013  More...
EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug 12/6/2013  More...
Pfizer Inc. (PFE), Hanmi Pharmaceutical, Co., Ltd Brawl Over Design Of Viagra Pill 12/5/2013  More...
pSivida Corp (PSDV) Reports ILUVIEN® To Be Funded By UK’s National Health Service For Treatment Of Pseudophakic Chronic DME Patients Following Issuance Of Final National Institute for Clinical Excellence (NICE) Guidance 12/2/2013  More...
U.K.'s National Institute for Clinical Excellence (NICE) Issues Final Guidance Recommending Alimera Sciences (ALIM)' ILUVIEN® 12/2/2013  More...
FDA Chastises Amgen (AMGN) For Aranesp Promotion 12/2/2013  More...
Princeton University Unlikely To Face Liability Over Novartis AG (NVS) Vaccine 12/2/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Additional Regulatory Exclusivity For TREANDA® (Bendamustine HCI) For Injection 11/27/2013  More...
FDA Lifts Constraints On GlaxoSmithKline (GSK) Diabetes Drug Avandia 11/26/2013  More...
Cornerstone Therapeutics Inc. Launches BETHKIS(R) (Tobramycin Inhalation Solution) For Management Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa 11/21/2013  More...
IMPAX Laboratories, Inc. (IPXL) Launches Generic Solaraze® (Diclofenac Sodium Gel, 3%) 11/21/2013  More...
Sosei Group Corporation: Once-Daily Ultibro® Inhalation Capsules (QVA149) For COPD Launched In Japan 11/20/2013  More...
Shire Canada Inc. Release: New ADHD Treatment Now Available In Canada: INTUNIV XR™ Offers Alternatives For Children Not Responding Well To Current Treatment 11/20/2013  More...
Omeros Corporation (OMER) Announces FDA Acceptance Of Omidria™ As Proprietary Name For OMS302 11/20/2013  More...
Par Pharmaceutical, Inc. Begins Shipment of Generic Focalin XR® Capsules 11/20/2013  More...
QPharma, Inc. Announces New Product Launch Solution 11/20/2013  More...
Skyepharma PLC (SKYEF)'s Partner Kyorin Launches Flutiform® In Japan 11/19/2013  More...
Sagent Pharmaceuticals, Inc. Announces The Launch Of Propofol Injectable Emulsion USP 1% 11/18/2013  More...
Actelion Ltd. (ALIOF.PK) Launches VALCHLOR (Mechlorethamine) Gel 0.016% In The U.S. 11/18/2013  More...
Mylan Inc. (MYL) Launches First Generic Focalin XR® Capsules, 30 mg 11/18/2013  More...
IntelliPharmaCeutics / Par Pharmaceutical, Inc. To Make Immediate Commercial Launch Of 15 And 30 mg Generic Focalin XR® 11/18/2013  More...
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013  More...
Targeted Medical Pharma Introduces New Dietary Supplement Clearwayz™ For Healthy Sinus And Immune Function 11/13/2013  More...
NicOx SA (COX.PA) Launches Sjö™ In The U.S. And Partners With The Sjogren's Syndrome Foundation 11/12/2013  More...
SOHM Launches SohMed™ Range Of Branded OTC Medicines In U.S. Market 11/12/2013  More...
National Institute for Clinical Excellence (NICE) Rejects Early Use Of Janssen-Cilag AG's Velcade For Multiple Myeloma 11/12/2013  More...
Nutra Pharma Corp. (NPHC) Provides Updates for the Marketing of Its All-Natural Pain Reliever, Nyloxin® 11/11/2013  More...
Mylan Inc. (MYL) Launches Generic Version of Aciphex® Tablets 11/11/2013  More...
Sagent Pharmaceuticals, Inc. Announces the Launch of Doxorubicin Hydrochloride Injection, USP 11/11/2013  More...
Amneal Pharmaceuticals Release: Generic Equivalent for Loestrin® 24 Fe Coming Soon 11/8/2013  More...
Discovery Laboratories (DSCO) Announces U.S. Commercial Launch of SURFAXIN® (lucinactant) 11/8/2013  More...
Allied Healthcare Group (AHZ:AU) Makes First Sale of Cardiocel ® Into Europe 11/8/2013  More...
Noven Pharmaceuticals Inc. Release: First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies 11/5/2013  More...
Sagent Pharmaceuticals, Inc. Announces the Launch of Carboplatin Injection 11/4/2013  More...
Actelion Ltd. (ALIOF.PK) Announces U.S. Commercial Availability of OPSUMIT® (macitentan) as of November 4 11/4/2013  More...
Furiex Pharmaceuticals, Inc. (FURX) Announces Priligy® Launch in the United Kingdom by Menarini Group 11/1/2013  More...
GlaxoSmithKline (GSK) Release: BREO® ELLIPTA™ Now Available in the U.S. for the Treatment of COPD 10/31/2013  More...
Depomed, Inc. (DEPO) Announces the Launch of Lazanda® (fentanyl) Nasal Spray and the Signature Support™ Program for Patients With Breakthrough Cancer Pain 10/28/2013  More...
National Institute for Clinical Excellence (NICE): Final Draft OK for Lucentis in Rare Eye Condition 10/25/2013  More...
ADImmune Corporation of Taiwan Readies Flu Vaccine for China 10/25/2013  More...
Eli Lilly and Company (LLY) Release: FDA Approves Addition to CIALIS® (tadalafil) Product Label 10/25/2013  More...
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria 10/24/2013  More...
Mission Pharmacal Company Launches Aquoral Oral Spray for Dry Mouth 10/23/2013  More...
Clontech Laboratories, Inc. Releases the SMARTer® Stranded RNA-Seq Kit 10/21/2013  More...
National Institute for Clinical Excellence (NICE) Draft "Yes" for Astellas Pharma Inc. (ALPMY)' Prostate Cancer Drug 10/18/2013  More...
DBV Technologies Announces Topline Financial Results for First Nine Months 2013 and Provides Safety Update on Viaskin® Peanut 10/15/2013  More...
Sagent Pharmaceuticals, Inc. Announces the Launch of Zoledronic Acid Injection 5 mg in a Premix Bag 10/14/2013  More...
China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization 10/9/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Sees Obstacles to Copying GlaxoSmithKline (GSK)'s Best-Selling Drug Advair Before 2018 10/9/2013  More...
Discovery Laboratories (DSCO) Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications 10/4/2013  More...
Did Pfizer Inc. (PFE) Have Jitters Over a Story About a Nerve Gas Antidote? 10/3/2013  More...
National Institute for Clinical Excellence (NICE) Backs Roche (RHHBY)'s MabThera in Rare Autoimmune Disease 10/3/2013  More...
Lupin Ltd. (LUPN.BO) Launches Generic ZYMAXID™ Ophthalmic Solution in the U.S. 10/3/2013  More...
Galena Biopharma  (GALE) Launches Abstral® (fentanyl) Sublingual Tablets for the Treatment of Breakthrough Cancer Pain 10/3/2013  More...
Shire plc Tries to Sell Its ADHD Pill in Europe, But Will Anyone Pay Attention? 10/3/2013  More...
ULURU Inc. Announces First Shipment of Altrazeal® to the Czech Republic, Slovakia and South African Marketing Partners 10/2/2013  More...
Mo Bio Laboratories, Inc. Launches a New Kit for Rapid Release of Microbial DNA From Swabs for PCR Analysis 10/2/2013  More...
Pacira Pharmaceuticals, Inc. Announces Partnership to Support Uptake of EXPAREL® Among the Orthopedic Marketplace 10/2/2013  More...
U.K.'s National Institute for Clinical Excellence (NICE) Issues Final Appraisal Determination Recommending Alimera Sciences (ALIM)'s ILUVIEN® for Chronic Diabetic Macular Edema 10/1/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Zemplar® in the United States 10/1/2013  More...
Mylan Inc. (MYL) Launches First Generic VFEND® for Oral Suspension 9/30/2013  More...





 

//-->